1. Introduction {#s1}
===============

Cognitive control dysfunction is one of the core deficits in schizophrenia. It is often manifested as problems in relating daily activities to internal goals and intentions ([@ref46]), and effective pharmacological treatment for these symptoms is still lacking ([@ref40]). A fronto-parietal brain network assembling around the dorsal anterior cingulate cortex (ACC) is considered the anatomical substrate of cognitive control processes ([@ref26]; [@ref57]; [@ref72]). Accordingly, anatomical ([@ref5]; [@ref20]) as well as functional ([@ref47]) alterations in this brain network have been reported in schizophrenia. These alterations are also reflected on the biochemical level, as revealed in studies using proton magnetic resonance spectroscopy (^1^H-MRS; [@ref52]). More specifically, studies on ACC and medial prefrontal cortex indicate that schizophrenia patients have alterations in the glutamate system ([@ref5]), often presenting as elevated glutamate levels as measured by ^1^H-MRS early in the disease, with a decrease or normalization with time and use of medication ([@ref44]; [@ref53]). Glutamate is the most widely distributed excitatory neurotransmitter in the brain and also acts as an intermediate in cerebral energy metabolism ([@ref59]). The glutamatergic hypothesis of schizophrenia is currently well recognized, claiming a crucial role of the glutamate system in the genesis of schizophrenia (see [@ref11] for a review), although presently the underlying abnormalities are not fully understood. The glutamatergic abnormalities have been linked to a possible excitatory/inhibitory imbalance related to N-methyl-[d]{.smallcaps}-aspartate (NMDA) and metabotropic receptors ([@ref11]; [@ref77]), in addition to a more indirect imbalance through ?-aminobutyric acid (GABA)ergic dysregulation ([@ref41]).

The combination of functional magnetic-resonance imaging (fMRI) and ^1^H-MRS constitutes a promising method for probing the relationship between glutamate and neuronal response during tasks and resting-state ([@ref14]; [@ref16]; [@ref19]; [@ref28]; [@ref37]; [@ref61]). Using this combined approach, we previously found that resting-state glutamate (rsGlu) levels in the ACC predicted the blood-oxygen level-dependent (BOLD) response in several brain regions when healthy individuals performed a cognitive control task ([@ref19]). Considering schizophrenia patients\' problems on tasks assessing cognitive control functions, together with the known glutamatergic pathology, we now suggest that glutamate differentially affects the BOLD response in schizophrenia patients and healthy individuals and that this is a mediating factor behind cognitive impairment in schizophrenia. Such a result would allow us to link glutamatergic mediation of neuronal activity at the metabolite-level to cognitive abnormalities found in schizophrenia. Moreover, we expected that patients with schizophrenia would show impaired performance on a cognitive control task and that the level of task performance would be moderated by glutamate levels.

2. Materials and methods {#s2}
========================

2.1. Participants {#s2.1}
-----------------

Seventeen patients with schizophrenia (DSM-IV/ICD-10) and 17 healthy participants matched for age, sex, and handedness participated in the study. Exclusion criteria were a history of neurological disorders, traumatic brain injuries, and metallic implants. Patients were assessed with the Positive and Negative Syndrome Scale (PANSS; [Table 1](#tbl1){ref-type="table"}; [@ref38]) and obtained a score of four or higher on the P3 Hallucinations-item (moderate to severe hallucinations). The patients were part of a general study on schizophrenia patients with auditory verbal hallucinations, and all were on atypical antipsychotic medication (olanzapine, clozapine, aripiprazole, quetiapine, paliperidone, or amisulpride). Due to the verbal nature of the cognitive control task (see below), hearing threshold was assessed with the Hughson--Westlake audiometric test (Oscilla USB-300, Inmedico, Lystrup, Denmark). Participants with an averaged inter-aural acuity difference of more than 10 dB were excluded. Eleven of the healthy participants were also part of a previous study ([@ref19]) and were included as control subjects for the schizophrenia patients based on the best match according to the above criteria. The study was approved by the Regional Committee for Medical Research Ethics in Western Norway (REK-Vest), and informed consent was obtained from all participants before the study.

2.2. Auditory cognitive control task {#s2.2}
------------------------------------

The experimental paradigm was a version of the Bergen dichotic listening task, which is an auditory speech perception task with simultaneous pair-wise presentations of consonant--vowel syllables (/ba/, /da/, /ga/, /ka/, /pa/, /ta/; see [@ref29] and [@ref18] for details). A stimulus-driven (bottom-up) and an instruction-driven (top-down) component were included in the paradigm so as to achieve systematic variation in the need for cognitive control. The bottom-up component was implemented by varying the stimulus salience through different levels of inter-aural sound intensity ([@ref32]; [@ref75]). Five levels of interaural intensity differences (IIDs) were used: 18 dB in favor of the left ear, 9 dB in favor of the left ear, no intensity difference, 9 dB in favor of the right ear and 18 dB in favor of the right ear. The stimulus was presented at a 70 dB sound pressure level (SPL) at both ears in the condition with no intensity difference. The other four conditions were presented with 70 dB SPL for the louder stimulus, while the weaker was reduced to either 61 or 52 dB SPL. The instruction-driven top-down component was applied by selectively directing the attention of the subject. The subjects were instructed to specifically focus and report from the right- (forced right condition, FR) or the left-ear stimulus (forced left condition, FL; [@ref29]; [@ref30]). The interaction between the bottom-up and top-down conditions thereby determines the demand for cognitive control, that is when the IID and attention instruction (ATT) are incongruent (e.g., attention focused on the left ear while the right ear is louder) there is higher need for cognitive control mechanisms than when IID and ATT are congruent ([@ref18]; [@ref76]).

The two attentional instructions (FR, FL) combined with the five levels of IID resulted in 10 experimental conditions. Each condition consisted of 18 dichotic presentations, resulting in a total of 180 stimulus presentations pseudo-randomly intermixed with 90 silent null-events. This created a stochastic event-related design for fMRI acquisition ([@ref24]), recorded in a single session. Attention instructions were randomly intermixed, preceded the stimuli by 1.5 s, and were given in writing through goggles mounted on the head coil (NordicNeuroLab Inc., Bergen, Norway). The dichotic syllables were presented at the beginning of the silent gaps of the sparse sampling protocol for the fMRI acquisition ([@ref70]) using headphones (NordicNeuroLab Inc.). The participants responded orally immediately after the stimulus by naming the syllable they heard, thereby avoiding movement artifacts during fMRI-acquisition. Stimulus administration and synchronization were performed using E-Prime software (version 2.0, Psychology Software Tools Inc., Pittsburgh, PA, USA).

2.3. Functional magnetic resonance imaging (fMRI) acquisition and analysis {#s2.3}
--------------------------------------------------------------------------

Imaging was performed on a 3.0 T GE Signa HDx scanner, using an eight-channel head coil. A short scout sequence and structural image were acquired first, followed by the fMRI and the ^1^H-MRS. Structural imaging was performed with a T1-weighted pulse sequence (Fast Spoiled Gradient, FSPGR; TR = 7.9 ms; TE = 3.1 ms; 11° flip angle) measuring 180 sagittal slices of 1 mm thickness (field of view, FOV (mm) = 256 × 256; 256 × 256 scan matrix).

fMRI was performed using an echo-planar imaging (EPI) sequence (TE = 30 ms; 90° flip angle) and was oriented to the structural image. A sparse sampling protocol was used (TR = 3.5 s, TA = 1.5 s) leaving a silent gap of 2.0 s between consecutive scans for task implementation, thereby reducing interference from scanner noise and avoiding movement artifacts during scanning. EPI volumes covered the cerebrum and most of the cerebellum, and contained 25 axial slices of 5 mm thickness (0.5 mm inter-slice gap; FOV 220 × 220 mm, 64 × 64 scan matrix), resulting in a voxel size of 3.44 × 3.44 × 5.0 mm. Image preprocessing and statistical analysis of the data were performed using Statistical Parametrical Mapping (SPM8) analysis software package (Wellcome Department of Cognitive Neurology, London, UK). The EPI images were realigned intra-individually to the first image in each time series and unwarped for correction of head movements and related image distortions. The images were then normalized to standard stereotactic space using the MNI-template and re-sampled to a cubic voxel size of 3 mm as well as smoothed using a 6 mm FWHM Gaussian filter. First-level individual statistical analysis of the fMRI data was set up as a model including a predictor for each of the 10 experimental conditions, and movement parameters were added as regressors. The predictors were convolved with the canonical hemodynamic response function (hrf) and a temporal high pass filter (cutoff at 128 s) was applied. The resulting individual beta-maps were used for the second-level group analysis.

For the fMRI group analysis, only four of the 10 conditions were included in order to investigate the BOLD response during cognitive control. This involved two conditions where the IID and attention were incongruent (FR with 18 dB in favor of the left ear, and FL with 18 dB in favor of the right), and two conditions with congruent IID and attention (FL with 18 dB in favor of the left ear, and FR with 18 dB in favor of the right). These conditions were thought to trigger high and low demands for cognitive control, respectively. The analysis was set up as a full factorial design within the framework of the general linear model, with the predictors attention instruction (ATT; 2 levels), interaural intensity difference (IID; 2 levels), and diagnosis (categorical factor). All analyses were performed using SPM8. We used an intensity threshold of *F* = 11.34 (equal to voxel-level *P* \< .001) and a cluster threshold of *k* = 50, which together produced an effective corrected *P* = 0.5 threshold (cluster-level; [@ref23]; [@ref79]). This method was applied due to its higher sensitivity to smaller effects, thus reducing the probability of type II errors ([@ref42]). Significant clusters were explored post-hoc using the SPM toolbox MarsBaR ([@ref6]) and MRIcroN software ([[http://www.cabiatl.com/mricro/mricron]{.ul}](http://www.cabiatl.com/mricro/mricron){#inter-ref001}). The anatomical location of each cluster was determined using Automated Anatomical Labeling ([@ref69]).

2.4. Magnetic resonance spectroscopy (^1^H-MRS) acquisition and analysis {#s2.4}
------------------------------------------------------------------------

An axial T2-weighted image was obtained prior to the ^1^H-MRS for voxel positioning. In vivo ^1^H-spectra were obtained from the bilateral dorsal ACC ([Fig. 1](#gr1){ref-type="fig"}) using a single voxel point resolved spectroscopy (PRESS) sequence (TR = 1500 ms, TE = 35 ms, voxel size 20 × 20 × 20 mm, 128 averages). The line-width was \<8 Hz and water suppression level at least 94%. The spectra were analyzed using LCModel fitting over the spectral range from 0.4 to 4.0 ppm (version 6.2-1A; [@ref54]), using a simulated basis-set of 16 metabolites for a TE of 35 ms ([l]{.smallcaps}-alanine, aspartate, creatine, phosphocreatine, GABA, glucose, glutamine, glutamate, glycerophosphocholine, phosphocholine, [l]{.smallcaps}-lactate, myo-inositol, N-acetyl aspartate, N-acetyl aspartate glutamate, taurine, and glycine). Resting-state glutamate values (rsGlu; relative to creatine) and total creatine concentration (creatine + phosphocreatine) were used from the LCModel output, only including results with a Cramer--Rao lower bound (CRLB) \< 20% ([Table 2](#tbl2){ref-type="table"} and Inline Supplementary Fig. S1). A three-way ANOVA with the factors rsGlu, hemisphere, and diagnosis was performed. Effect-size measures were calculated as percentage explained variance (?^2^), and post-hoc analyses were performed using Fisher\'s LSD.

Supplementary Figure S1Fig. S1Representative ^1^H-MRS spectra from the four glutamate-groups. Spectra were acquired by LCModel from four individuals representing the four groups. The absorption peak from which glutamate is measured is marked by an asterisk (\*). SZ, schizophrenia patients; HC, healthy controls; rsGlu, resting-state glutamate.

Inline Supplementary Fig. S1 can be found online at <http://dx.doi.org/10.1016/j.nicl.2014.03.014>.

### 2.4.1. Control of possible confounding factors {#s2.4.1}

As glutamate levels might depend on the amount of gray and white matter within the measured voxel ([@ref64]), and differences in ACC gray matter have been reported within healthy individuals ([@ref34]) and between healthy controls and schizophrenia patients ([@ref20]), it was important to test for whether anatomical differences within the voxels could confound the rsGlu values. The proportion of gray and white matter in each region was calculated using scripts developed in-house, leveraging the SPM8 package\'s combined segmentation and spatial normalization functions. Coordinates and orientation in scanner space were read directly from the raw spectroscopy data files (P\*.7, GE P-file format). A structural T2 reference image acquired immediately before the spectroscopy data was coregistered against a higher-resolution T1 image acquired earlier in the session; the resulting rigid body transformation was applied to the spectroscopy voxel coordinates to compensate for any patient movement between the two scans. The structural T1 image was subsequently coregistered to a standard MNI template and segmented into tissue probability maps for three classes of tissue (gray matter, white matter and CSF). These maps were integrated over each transformed spectroscopy voxel to obtain final estimates of region content. However, neither gray matter (*r* = 0.25, 0.07, 0.02, -0.06, for SZ left, SZ right, HC left, and HC right, respectively), white matter (*r* = -0.31, 0.00, -0.03, 0.12), nor total brain volume (*r* = -0.11, -0.01, -0.35, 0.05) correlated significantly (*P* \< .05) with rsGlu levels. Thus, we consider it unlikely that individual differences in ACC structure influenced the reported rsGlu levels in our sample. Additionally, rsGlu levels correlated with neither age (SZ left: *r* = -0.18, SZ right: *r* = -0.28, HC left: *r* = -0.22, HC right: *r* = -0.1) nor duration of illness (SZ left: *r* = 0.19, SZ right: *r* = -0.22).

Creatine is commonly used as an internal reference in ^1^H-MRS. However, since creatine abnormalities have been found in schizophrenia patients ([@ref49]) we performed a three-way ANOVA with the factors creatine (Cr + PCr total concentration values, dependent variable), hemisphere (2 levels; right and left) and diagnosis (categorical factor) in order to control for possible creatine differences. Since there were no significant interactions of creatine with either hemisphere (*P* = .62) or diagnosis (*P* = .20), we concluded that the use of creatine as an internal standard was valid.

2.5. Combined fMRI--^1^H-MRS analysis {#s2.5}
-------------------------------------

The contrast images between the incongruent and congruent conditions from the individual first-level fMRI analyses were included as a dependent variable in the combined analysis (full factorial). RsGlu values (continuous, between-subjects factor; z-standardized) and diagnosis (categorical factor), together with the interaction between the two were included as predictors ([@ref9]). An intensity threshold of *t* = 3.39 (equivalent to voxel-level *P* \< .001) together with a cluster threshold of *k* = 50 was used to yield an effective corrected *P* = 0.05 threshold ([@ref79]).

2.6. Task performance analysis {#s2.6}
------------------------------

The behavioral data from the dichotic listening task (same four conditions as for the fMRI-analysis) were analyzed with a five-way factorial ANOVA with rsGlu (2 levels; high and low) and diagnosis (2 levels; SZ and HC) as categorical factors, together with the repeated-measures factors ATT (2 levels), IID (2 levels), and ear (2 levels; right and left ears). This was done for both right and left hemisphere glutamate, separately. The concept of interest in the present study was the ability of cognitive control, which was defined as the interaction between ATT, IID and ear (see e.g., [@ref18]; [@ref51]; [@ref76]). Hence, the four- and five-way interactions, respectively, of these three factors together with glutamate and diagnosis were the effects of interest in this analysis. For this reason, and based on the omnibus ANOVA (see below), post-hoc three-way ANOVAs with the factors ATT, IID and ear were performed for the four 'glutamate groups' in order to determine the effect sizes separately for each group (SZ low rsGlu, SZ high rsGlu, HC low rsGlu, HC high rsGlu). Here, we were interested in the possible difference in how the groups managed to utilize top-down mechanisms and respond to the "correct" ear (represented by the interaction between ATT and ear) and how they were driven by the bottom-up perceptual salience (the interaction of IID and ear). Further post-hoc analyses were performed using Fisher\'s LSD and effect-size measures were calculated as explained variance (?^2^).

3. Results {#s3}
==========

3.1. fMRI {#s3.1}
---------

The statistical analysis showed a significant difference in BOLD response between the groups in the right middle occipital gyrus/angular gyrus (BA 19/39), as indicated by a three-way interaction between diagnosis, ATT and IID (Inline Supplementary Fig. S2 and Inline Supplementary Fig. S3). The post-hoc analysis showed that SZ had higher BOLD response in this region during high demand for cognitive control than HC.

Supplementary Figure S2Fig. S2Overall fMRI BOLD response from the auditory cognitive control task. Showing the results for the schizophrenia patients (SZ) and healthy controls (HC) separately, together with the combined BOLD response over the two groups (*P* \< .001, extent threshold *k* = 50 voxels). See [@ref18] and [@ref76] for a more detailed discussion of the above regions and the dichotic listening task in healthy individuals.

Supplementary Figure S3Fig. S3Group difference in fMRI BOLD response. The red cluster shows the region where schizophrenia patients (SZ) show higher BOLD response during high demands for cognitive control compared to healthy controls (HC; *P* \< .001, extent threshold *k* = 50 voxels). The blue cluster indicates the region influenced by glutamate levels (see also [Fig. 2](#gr2){ref-type="fig"}). LE, left ear; RE, right ear; FR, forced-right attention condition; FL, forced-left condition; "+" indicates the ear with louder (by 18 dB) sound intensity.

Inline Supplementary Figs. S2--S3 can be found online at <http://dx.doi.org/10.1016/j.nicl.2014.03.014>.

3.2. ^1^H-MRS {#s3.2}
-------------

The statistical analysis of the ^1^H-MRS glutamate data showed a significant interaction between hemisphere and diagnosis (*P* \< .05, *F* = 4.63, ?^2^ = .04), with the post-hoc analysis revealing that SZ had lower levels of rsGlu in the left ACC than HC. A significant main effect of hemisphere (*P* \< .001, *F* = 19.7, ?^2^ = 0.17) was also driven by lower levels of rsGlu in the left ACC in SZ only. Due to the significant difference in rsGlu between SZ and HC in the left ACC, all further analyses were performed separately for both hemispheres. The main effect for diagnosis was not significant.

3.3. Combined fMRI--^1^H-MRS {#s3.3}
----------------------------

The statistical analysis of the combined fMRI--^1^H-MRS data revealed a significant modulation by right ACC glutamate, as indicated by a three-way interaction between diagnosis, rsGlu and BOLD response. This interaction was found bilaterally in the inferior parietal lobe (IPL; BA 39/40), with the right-hemispheric cluster located more ventrally (reaching angular gyrus, see [Fig. 2](#gr2){ref-type="fig"}). As shown in [Fig. 2](#gr2){ref-type="fig"}, right rsGlu moderates the BOLD response differentially in SZ and HC, with BOLD response in the bilateral IPL correlating positively with rsGlu in SZ under high demands for cognitive control, while this relationship is negative in HC. As expected, there was no interaction between rsGlu and ACC BOLD response (see [@ref19]). Moreover, left rsGlu did not show any significant interactions with the BOLD response.

3.4. Task performance {#s3.4}
---------------------

The four-way interactions between ATT, IID, ear, and glutamate or diagnosis were not significant, but the five-way interaction between ATT, IID, ear, rsGlu, and diagnosis showed a clear trend towards significance (*P* = .07, n^2^ = .01; Inline Supplementary Table 1). Based on their rsGlu levels, SZ and HC were median-split into low- (*n* = 8/8; SZ: rsGlu = 1.47 ± 0.11; HC: rsGlu = 1.53 ± 0.07) and high-glutamate (*n* = 9/9; SZ: rsGlu = 1.81 ± 0.15; HC: rsGlu = 1.77 ± 0.13) groups. Separate ANOVAs performed for each right ACC glutamate group showed that the four groups differed strongly in how much they were influenced by the bottom-up sound intensity manipulation ([Fig. 3](#gr3){ref-type="fig"}, Inline Supplementary Table 2). While high rsGlu SZ and both HC groups displayed moderate to large effect sizes for the interaction between IID and ear, the performance of low rsGlu SZ appeared to be mostly driven by the IID during task response. Additionally, the interaction between ATT and ear, showing the ability to follow the attention instruction by using top-down cognitive control, gave moderate to large effect sizes in the HC only. By comparison, the interaction between ATT, IID, and ear did not explain much variance in any of the groups. Other significant main effects and interactions in the five-way ANOVA not related to rsGlu or diagnosis have been discussed in previous analyses of similar data ([@ref18]; [@ref76]). Left hemisphere rsGlu showed no significant main effect or interaction with task performance.

Supplementary Table S1Supplementary Table S1Task performance. Results of a five-way ANOVA with the factors resting-state glutamate, diagnosis, attention instruction, intensity difference, and ear.*F*df~effect~df~error~n^2^*P* valuersGlu2.45138.02.13diagn1.61138.01.21rsGlu \* diagn0.011380.90ATT7.751380.01ATT \* rsGlu3.821380.06ATT \* diagn0.131380.72ATT \* rsGlu \* diagn0.511380.48IID0.191380.67IID \* rsGlu1.511380.23IID \* diagn0.051380.83IID \* rsGlu \* diagn0.051380.83ear7.77138.12.01ear \* rsGlu0.62138.01.43ear \* diagn0.87138.01.36ear \* rsGlu \* diagn0.59138.01.45ATT \* IID4.65138.03.04ATT \* IID \* rsGlu0.171380.68ATT \* IID \* diagn4.63138.03.04ATT \* IID \* rsGlu \* diagn2.95138.02.09ATT \* ear12.46138.05.00ATT \* ear \* rsGlu2.37138.01.13ATT \* ear \* diagn3.73138.02.06ATT \* ear \* rsGlu \* diagn0.731380.40IID \* ear7.97138.14.01IID \* ear \* rsGlu5.67138.10.02IID \* ear \* diagn6.31138.11.02IID \* ear \* rsGlu \* diagn0.40138.01.53ATT \* IID \* ear0.211380.65ATT \* IID \* ear \* rsGlu1.031380.32ATT \* IID \* ear \* diagn0.011380.91ATT \* IID \* ear \* rsGlu \* diagn3.48138.01.07[^1]Supplementary Table S1

Supplementary Table S2Supplementary Table S2Effect sizes (?^2^) from the separate ANOVAs of the task performance for the glutamate groups.SZ lowSZ highHC lowHC highATT \* ear0.0080.0250.1310.136[a](#tblfn1){ref-type="table-fn"}IID \* ear0.6250.282[a](#tblfn1){ref-type="table-fn"}0.0880.274[a](#tblfn1){ref-type="table-fn"}ATT \* IID \* ear0.0010.0010.0010.004[^2][^3]Supplementary Table S2

Inline Supplementary Tables S1--S2 can be found online at <http://dx.doi.org/10.1016/j.nicl.2014.03.014>.

4. Discussion {#s4}
=============

The present results indicate that glutamate measured in the ACC differentially predicts the neuronal response to cognitive control in schizophrenia patients and healthy individuals. Schizophrenia patients with higher levels of rsGlu showed increased BOLD response in the bilateral IPL during high demands for cognitive control, while patients with lower rsGlu did not show a comparable effect. However, the opposite was true for the healthy individuals. Here only individuals with lower levels of rsGlu showed an effect, while healthy individuals with higher rsGlu did not ([Fig. 2](#gr2){ref-type="fig"}). In general, the IPL is found to be involved in detection of new events and sustained attention over time ([@ref33]), both in the visual and auditory domains ([@ref10]; [@ref60]; [@ref76]). Moreover, the IPL has been implicated in linguistic functions as part of the phonological--articulatory loop, acting as a feed-forward area between auditory temporal areas and frontal speech production areas ([@ref55]). [@ref55] propose that the IPL acts as an interface in speech perception through its role in attention modulation and its connections to both frontal and superior temporal regions. It has also been suggested that attentional mechanisms of the IPL are directly modulated by conflict detection and top-down modulation from the ACC ([@ref26]), an observation which has been strengthened by the detection of high intrinsic functional connectivity of the IPL with other hubs of the frontoparietal control system, including the ACC ([@ref72]). Finally, coactivation of ([@ref18]; [@ref60]; [@ref78]) and strong anatomical connections between ([@ref4]; [@ref50]) the IPL and ACC further support the notion of a functional link between these two brain regions during cognitive control processes. Thus, these previous findings corroborate well with the connection found between ACC glutamate and IPL BOLD response.

However, the presence of a link between ACC and IPL in healthy subjects does not provide an explanation as to why the relationship is inverted in schizophrenia. Schizophrenia patients are generally found to engage the ACC and IPL during high demands for cognitive control, as also shown in the present fMRI-results, although often with reduced strength when compared with healthy individuals ([@ref8]; [@ref40]; [@ref47]). Moreover, anatomical abnormalities have been found in both the ACC ([@ref5]; [@ref20]) and the IPL ([@ref62]; [@ref68]) in schizophrenia patients, together with altered integrity in white-matter tracts connecting these and other regions considered to take part in cognitive control processes ([@ref56]; [@ref63]). Notably, reduced functional connectivity within the frontal--parietal--temporal language network has been found in patients with auditory hallucinations during language processing ([@ref13]; [@ref45]), and during resting-state fMRI, patients with auditory hallucinations exhibit reduced connectivity between parietal areas and the ACC ([@ref71]). Reduced or abnormal connectivity in general, and between frontal and parietal regions in particular, is also a central feature of several theories of auditory hallucinations in schizophrenia ([@ref3]; [@ref22]; [@ref31]; [@ref74]). Related to this, our findings show that only patients with high (right-sided) ACC rsGlu levels engage IPL regions. This could be conceived as a functional disconnection between these regions, which thus is glutamatergically mediated by either direct synaptic activity or neuronal metabolism. Indeed, when it comes to synaptic glutamate, a recent study found that by disrupting glutamatergic neurotransmission through the administration of NMDA antagonist ketamine, long- and short-range circuit communication was impaired both in the fronto-parietal task-positive and in the default-mode network ([@ref2]). Ketamine was also found to invoke schizophrenia-like symptoms and to affect cognitive performance ([@ref2]), possibly through increased glutamate levels ([@ref25]; [@ref65]). Altered glutamate-dependent intrinsic circuitry has also been demonstrated in the ACC in schizophrenia ([@ref5]; [@ref77]), which might contribute to modified connectivity with other regions. Moreover, the task-positive networks are found to undergo critical re-modeling during development ([@ref17]), and as hypothesized by [@ref56], it is possible that this re-modeling is disrupted during puberty in individuals that develop schizophrenia, affecting distal connectivity in particular. Since distal corticocortical connections in the brain are mainly glutamatergic, our results could support this view by showing altered glutamate-dependent communication between distal regions in schizophrenia. Thus, the functional connectivity between the ACC and the IPL might be disturbed or desynchronized in schizophrenia patients due to differences in glutamate-dependent modulation of neuronal activity, measured as changes in the BOLD response, also leading to reduced connectivity in more widespread cognitive control and language networks.

This assumption can furthermore be supported by the findings of [@ref35], also applying the combined fMRI--MRS method in schizophrenia patients. The authors report that hippocampal glutamate levels mediate the BOLD response in the inferior frontal gyrus during a memory task in healthy controls. Similar to the present results, schizophrenia patients showed a different pattern of long-range glutamatergic connections during a cognitively demanding task. Previous studies in healthy individuals have found a glutamatergic relationship with regional task-induced BOLD, resting-state BOLD, and with the functional connectivity between regions ([@ref14]; [@ref15]; [@ref16]; [@ref19]; [@ref28]; [@ref37]; [@ref61]). Thus, future studies both in schizophrenia patients and in healthy individuals could benefit from including both task-based and resting state fMRI in order to investigate the glutamatergic influence on the BOLD response in local microcircuits and larger cognitive networks, and maybe its role in the transition between default-mode brain activity and task-related brain responses (see e.g., [@ref21]).

Based on the current results, it is however difficult to conclude whether the glutamate-associated BOLD response in the IPL is functionally beneficial or not. Seeing the response as a compensatory mechanism, high glutamate levels in the ACC would be an advantage, possibly through higher rates of energy turnover in this brain region ([@ref43]; [@ref59]), and thus IPL engagement might not be necessary. On the other hand, if the IPL is seen as (a) an essential part of cognitive control mechanisms through the fronto-parietal control network ([@ref72]), and/or (b) important for correct auditory processing through the phonological-articulatory loop ([@ref55]), an insufficient recruitment of the IPL would be disadvantageous. Considering the schizophrenia patients\' performance on the present task, it appears that low rsGlu levels and a lack of IPL activation are disadvantages, as the patients were exclusively and very strongly influenced by the sound intensity and did not manage to employ control resources to overcome the bottom-up intensity differences ([Fig. 3](#gr3){ref-type="fig"}). In SZ with higher levels of rsGlu, the sound intensity influenced task performance to a lesser degree, but they still struggled with applying control. This could perhaps reflect that the latter subgroup put more effort into following the attention instructions, but that the attempt failed (with attention instruction only explaining a small amount of variance). However, neither diagnosis nor glutamate levels alone can explain this difference in task performance (Inline Supplementary Table 1), suggesting that higher levels of glutamate could act as a kind of "buffer" for the schizophrenia patients, which prevents them from showing marked cognitive control deficits. Moreover, the schizophrenia patients showed a generally higher BOLD response during task performance in the right middle occipital gyrus/angular gyrus (BA 19/39) compared to healthy controls, an area adjacent to the glutamate-influenced IPL regions (cf. Inline Supplementary Fig. S3). Together with the engagement of the IPL in patients with higher rsGlu levels, this might prove an additional compensatory neuronal recruitment in these individuals, thereby improving their capability for cognitive control processing. In healthy individuals, however, both glutamate-groups managed to follow instructions and to correctly report the syllable from the to-be attended ear. This indicates that higher levels of glutamate in the ACC may not necessarily be task-relevant or even beneficial in healthy individuals ([@ref19]).

Widespread dysfunction of glutamate neurotransmission is thought to be a part of the pathology behind schizophrenia and is currently under extensive investigation regarding antipsychotic treatment ([@ref48]). Hypofunction of the glutamatergic NMDA receptor seems to be related to schizophrenia symptoms ([@ref12]), further leading to disinhibition of glutamatergic neurons and desynchronized neural activity through hypostimulation of the GABAergic system ([@ref11]; [@ref41]). Moreover, several ^1^H-MRS schizophrenia studies have found alterations in glutamate levels, although results differ depending on voxel location and disease duration. A general finding has been increased levels of medial frontal glutamate (or combined glutamate and glutamine, glx) in early stages of the disease ([@ref67]) with levels decreasing or normalizing over time ([@ref44]; [@ref66]; see [@ref53] for a review), possibly due to excitotoxicity or the use of antipsychotic medication ([@ref39]). We found lower levels of rsGlu compared to healthy individuals in the left ACC, corroborating previous results in chronic samples. The hemispheric difference in our study was not expected, and is difficult to explain compared with previous results since most ^1^H-MRS studies place the ACC voxels either across the hemispheres or in one hemisphere only. However, the fact that this difference was found only in the left ACC, and that only right ACC rsGlu interacted with the BOLD response, could indicate a hemispheric imbalance related to glutamatergic regulation in neuronal signaling or local metabolism. Perhaps glutamatergic reduction in the left ACC disturbs cognitive control processing depending on the right ACC, thus contributing to the inverted pattern seen in our results. Generally, this inter-hemispheric difference could be important and should be more thoroughly investigated in future studies.

The current study had several limitations. Firstly, our schizophrenia patients were all on antipsychotic medications, so that medication effects on the results cannot be excluded. Previous clinical as well as animal studies have shown that atypical antipsychotic medication may reduce or normalize glutamate levels in medial frontal regions ([@ref7]; [@ref39]). This might be the origin of the reduced rsGlu in left ACC in our results, but would not have any direct impact on the main outcome of the present results, as left-hemisphere rsGlu did not influence the BOLD response. Moreover, none of the currently available antipsychotic medications target the glutamate system directly. Another study has shown that the BOLD response in schizophrenia patients tends to normalize over longer exposure to antipsychotic medications ([@ref1]). Given the chronic state of the current patient sample, the antipsychotic medications could contribute to the absence of any large between-groups difference in the present fMRI analysis alone. Secondly, at 3 T field strength some of the metabolite peaks in the ^1^H-MRS spectrum are overlapping. In spite of the high quality of the glutamate output from the LCModel, it is difficult to completely discriminate glutamate from glutamine and GABA signal amplitudes. However, a PRESS sequence with short echo time as we used here is not sensitive to GABA ([@ref27]), and although GABA and glutamate are involved in the same neurotransmitter cycling, they have been found not to correlate within an MRS-voxel ([@ref73]). Regarding glutamine, future studies using e.g. 2D J-resolved are warranted for full separation ([@ref36]). Thirdly, due to time limitation, ^1^H-MRS was only assessed in the ACC. Future studies might benefit from the inclusion of a control measurement region in order to distinguish regional specific effects from possible global effects. In addition, the present study only included schizophrenia patients with moderate to severe auditory verbal hallucinations, thus the results may not generalize to all individuals with schizophrenia.

5. Conclusions {#s5}
==============

Taken together, the present study indicates glutamate-dependent differences in the engagement of the IPL during cognitive control processing in schizophrenia patients, also showing that cognitive control performance is affected by glutamate levels. The differential glutamate-dependent BOLD response can be seen as an important link between metabolite-level glutamate deficits and cognitive control challenges in schizophrenia, thus implying a more widespread, network-dependent pathology in schizophrenia. Ultimately, these results provide information on glutamate mechanisms that can be of relevance regarding pharmacological development targeting the glutamatergic system.
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![Voxel placements for the ^1^H-MRS in the bilateral dorsal anterior cingulate cortex.](gr1){#gr1}

![Results from the combined fMRI--^1^H-MRS analysis, showing the regions where right ACC resting-state glutamate (rsGlu) differentially moderates the BOLD response in the cognitive control task (*P* \< .001, extent threshold *k* = 50 voxels). Schizophrenia patients (SZ) and healthy controls (HC) display a positive and negative correlation, respectively, between BOLD response and right rsGlu. IPL, inferior parietal lobe; L, left; R, right.](gr2){#gr2}

![Task performance for the four glutamate-groups. Effect sizes (?^2^) are shown for the four groups\' degree of sound intensity dependency (i.e., the effect size of the IID × ear interaction) and the capability for attentional modulation (i.e., the effect size of the ATT × ear interaction) of the auditory cognitive control task. IID, interaural intensity difference; ATT, attention instruction.](gr3){#gr3}

###### 

Demographic and clinical characteristics.

  Characteristics                                                                                              SZ (*n* = 17)   HC (*n* = 17)
  ------------------------------------------------------------------------------------------------------------ --------------- ---------------
  Age (mean)                                                                                                   30 ± 10         28 ± 4
  Sex, no.                                                                                                                     
  Female                                                                                                       7               7
  Male                                                                                                         10              10
  Duration of illness, years (mean)[a](#ngtbl1.1){ref-type="table-fn"}^,^[b](#ngtbl1.2){ref-type="table-fn"}   9 ± 5           --
  Handedness, right/left                                                                                       14/3            14/3
  PANSS scores (mean)[a](#ngtbl1.1){ref-type="table-fn"}                                                                       
  Positive total                                                                                               18 ± 6          --
  Negative total                                                                                               16 ± 6          --
  General total                                                                                                30 ± 8          --
  PANSS total                                                                                                  64 ± 17         --

± indicates SD.

SZ, schizophrenia patients; HC, healthy controls; PANSS, Positive and Negative Syndrome Scale.

*n* = 16, data missing for one patient.

Duration = years, from onset of symptoms.

###### 

^1^H-MRS values.

              SZ                                                                                   HC                                                                                                
  ----------- ------------------------------------------------------------------------------------ ------------------------------------------------ ------------------------------------------------ ---------------
  rsGlu/Cre   1.44 ± 0.15[a](#nstbl2.1){ref-type="table-fn"},[b](#nstbl2.2){ref-type="table-fn"}   1.65 ± 0.21[b](#nstbl2.2){ref-type="table-fn"}   1.59 ± 0.18[a](#nstbl2.1){ref-type="table-fn"}   1.66 ± 0.16
  FWHM        0.039 ± 0.006                                                                        0.045 ± 0.006                                    0.038 ± 0.004                                    0.045 ± 0.008
  S/N         20.24 ± 3.21                                                                         18.41 ± 2.67                                     22.76 ± 2.08                                     20.06 ± 2.54
  CRLB %      8 ± 1.87[a](#nstbl2.1){ref-type="table-fn"}                                          7.53 ± 1.12                                      6.65 ± 0.61[a](#nstbl2.1){ref-type="table-fn"}   6.94 ± 0.75
  GM          34.2 ± 6.68                                                                          32.32 ± 7.1                                      35.14 ± 5.52                                     34.66 ± 5.8
  WM          62.53 ± 7.6                                                                          64.4 ± 7.65                                      62.46 ± 7.1                                      62.42 ± 6.91

± indicates SD.

SZ, schizophrenia patients; HC, healthy controls; rsGlu/Cre, resting-state glutamate relative to creatine; FWHM, full-width-at-half-maximum; S/N, signal-to-noise ratio; CRLB, Cramer--Rao lower bound; GM, gray matter proportion in voxel; WM, white matter proportion in voxel.

*P* \< .05 significant difference between SZ and HC.

*P* \< .05 significant difference between the two hemispheres.

[^1]: rsGlu, resting-state glutamate level (high or low, right hemisphere); diagn, diagnosis (schizophrenia patient or healthy control); ATT, attention instruction; IID, interaural intensity difference.

[^2]: SZ, schizophrenia patients; HC, healthy controls; ATT, attention instruction; IID, interaural intensity difference.

[^3]: significant at *P* \< .05.
